CO4650183A1 - Derivados del pirrol - Google Patents

Derivados del pirrol

Info

Publication number
CO4650183A1
CO4650183A1 CO95056926A CO95056926A CO4650183A1 CO 4650183 A1 CO4650183 A1 CO 4650183A1 CO 95056926 A CO95056926 A CO 95056926A CO 95056926 A CO95056926 A CO 95056926A CO 4650183 A1 CO4650183 A1 CO 4650183A1
Authority
CO
Colombia
Prior art keywords
group
halo
rent
independently
alkyl
Prior art date
Application number
CO95056926A
Other languages
English (en)
Inventor
Jim W Barnett
Denis J Kertesz
Aaron B Miller
David John Morgans Jr
Chakk S Ramesha
Sigal Elliot Sigal
Eric Brian Sjobren
Francisco X Talamas
David B Smith
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CO4650183A1 publication Critical patent/CO4650183A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

REIVINDICACION NUMERO UN COMPUESTO QUE TENGA LA ESTRUCTURA: FIGURA 1 DONDE: R1 ES -H, EL GRUPO ALQUILO INFERIOR, ALQUILO HALO- INFERIOR, ACETILO, ACETILO SUSTITUIDO, -(CHR24) (CH2)nR14, -(CHR24) (CH2)nC(O)15, -(CHR24) (CH2)n C(O)NR16R17 O BIEN -CHR24R18; DONDE n ES UN NUMERO ENTERO DEL 1 AL 5, R14 ES -CN, -OH, GRUPO ALCOXI INFERIOR, AXILOXI INFERIOR, ACILOXI SUSTITUIDO, DIALQUILAMINO INFERIOR, ALQUILTIO INGERIOR, AL- QUILSULFONILO INFERIOR, ALQUENO INFERIOR, ALQUINO INFERIOR O BIEN METANOSULFONAMIDO; R15 ES EL GRUPO ALCOXI INFERIOR; R16 Y R17 SE SELECCIONAN, INDE- PENDIENTEMENTE, DEL GRUPO FORMADO POR LOS RADICA- LES -H Y ALQUILO INFERIOR; R18 ES: FIGURA 2 DONDE R19 Y R20 SE SELECCIONAN INDEPENDIENTEMENTE, DEL GRUPO FORMADO POR LOS RADICALES -CN, HALO AL- COXI INFERIOR Y ALQUILO INFERIOR; Y R24 ES EL GRU- PO -H, ALQUILO INFERIOR O FENILO: R2 Y R3 SE SELECCIONAN, INDEPENDIENTEMENTE, DEL GRUPO FORMADO POR -H, HALO Y -CH3; R4 ES -H, ALQUILO INFERIOR O -CN R5 ES -H O EL ALQUILO INFERIOR; R6 Y R7 SE SELECCIONAN, INDEPENDIENTEMENTE, DEL GRUPO FORMADO POR -H, HALO, ALQUILO INFERIOR, AL- COXI INFERIOR Y ALQUILTIO INFERIOR; Y FIGURA 3 DONDE R9 ES -H, EL GRUPO HALO, ALQUILO INFERIOR, HALO-ALQUILO INFERIOR, AMINO, DIALQUILAMINO INFE- RIOR, ALQUILAMIDO INFERIOR, ALQUILTIO INFERIOR, ALCOXI INFERIOR, ALCOXI INFERIOR, ALQUENO INFERIOR O ALQUINO INFERIOR; R10 Y R11 SE SELECCIONAN, IN- DEPENDIENTEMENTE, DEL GRUPO FORMADO POR -H, HALO Y -CH3; Y R12 ES -H, -Cl o CH3; O LAS SALES DE LOS MISMOS ACEPTABLES DESDE UN PUNTO DE VISTA FARMA- CEUTICO. / / / /
CO95056926A 1994-12-01 1995-11-30 Derivados del pirrol CO4650183A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/347,915 US5622948A (en) 1994-12-01 1994-12-01 Pyrrole pyridazine and pyridazinone anti-inflammatory agents

Publications (1)

Publication Number Publication Date
CO4650183A1 true CO4650183A1 (es) 1998-09-03

Family

ID=23365840

Family Applications (1)

Application Number Title Priority Date Filing Date
CO95056926A CO4650183A1 (es) 1994-12-01 1995-11-30 Derivados del pirrol

Country Status (19)

Country Link
US (1) US5622948A (es)
EP (1) EP0714895A1 (es)
JP (1) JPH08208639A (es)
KR (1) KR960022506A (es)
CN (1) CN1066726C (es)
AR (1) AR001771A1 (es)
AU (1) AU3906295A (es)
BR (1) BR9505610A (es)
CA (1) CA2163490A1 (es)
CO (1) CO4650183A1 (es)
CZ (1) CZ316995A3 (es)
FI (1) FI955783A (es)
HU (1) HUT75117A (es)
IL (1) IL116139A0 (es)
MA (1) MA23735A1 (es)
NO (1) NO954878L (es)
PL (1) PL311536A1 (es)
TR (1) TR199501528A1 (es)
ZA (1) ZA9510027B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622948A (en) * 1994-12-01 1997-04-22 Syntex (U.S.A.) Inc. Pyrrole pyridazine and pyridazinone anti-inflammatory agents
US6231888B1 (en) 1996-01-18 2001-05-15 Perio Products Ltd. Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
CN1136197C (zh) * 1996-05-30 2004-01-28 霍夫曼-拉罗奇有限公司 新的哒嗪酮衍生物
DE69716061T2 (de) * 1996-05-30 2003-08-14 F. Hoffmann-La Roche Ag, Basel Pyrrolderivate
CN1167687C (zh) * 1997-08-22 2004-09-22 艾博特公司 作为前列腺素胞内过氧化物h合酶生物合成抑制剂的芳基哒嗪酮
WO1999010331A1 (en) * 1997-08-22 1999-03-04 Abbott Laboratories Arylpyridazinones as prostaglandin endoperoxide h synthase biosynthesis inhibitors
US6307047B1 (en) * 1997-08-22 2001-10-23 Abbott Laboratories Prostaglandin endoperoxide H synthase biosynthesis inhibitors
US6525053B1 (en) 1997-08-22 2003-02-25 Abbott Laboratories Prostaglandin endoperoxide H synthase biosynthesis inhibitors
MXPA00004036A (es) * 1997-10-27 2006-05-24 Reddys Lab Ltd Dr Compuestos triciclicos novedosos y su uso en medicina; proceso para su preparacion y composiciones farmaceuticas que los contienen..
US6531152B1 (en) 1998-09-30 2003-03-11 Dexcel Pharma Technologies Ltd. Immediate release gastrointestinal drug delivery system
TR200101765T2 (tr) * 1998-10-27 2002-02-21 Abbott Laboratories Prostaglandin endoperoksit H sentaz biyosentez inhibitörleri
US6632451B2 (en) 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
ATE445838T1 (de) 2001-07-25 2009-10-15 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
CA2492022A1 (en) * 2002-07-11 2004-01-22 Merck & Co., Inc. Treatment of neuropathic pain with 6h-pyrrolo[3,4-d]pyridazine compounds
EP2671508B1 (en) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-informatics system
GB0610680D0 (en) * 2006-05-31 2006-07-12 Istituto Di Ricerche D Biolog Therapeutic compounds
CA2663377A1 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
JP5758630B2 (ja) * 2007-11-15 2015-08-05 エンメエッセディ・イタリア・エッセ・エッレ・エッレ Parp阻害剤としてのピリダジノン誘導体
HUE059078T2 (hu) 2009-02-20 2022-10-28 Enhanx Biopharm Inc Glutation-alapú hatóanyagszállító rendszer
JP2012526144A (ja) 2009-05-06 2012-10-25 ラボラトリー スキン ケア インコーポレイテッド 活性物質−リン酸カルシウム粒子複合体を含む経皮送達組成物およびその使用方法
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
EP2527335B1 (en) 2011-04-26 2013-09-18 King Saud University Triazole compounds as anti-inflammatory agents
KR102233456B1 (ko) 2017-05-31 2021-03-29 주식회사 대웅제약 4-메톡시피롤 유도체의 중간체 제조 방법
KR102233455B1 (ko) 2017-06-21 2021-03-29 주식회사 대웅제약 4-메톡시피롤 유도체의 중간체 제조 방법
WO2022159980A1 (en) * 2021-01-25 2022-07-28 Athos Therapeutics, Inc. Pharmaceutical compounds and methods of making and using the same

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2316942A (en) * 1937-12-27 1943-04-20 Schlumberger Well Surv Corp Apparatus for measuring temperatures in boreholes
US3726978A (en) * 1967-11-02 1973-04-10 Sandoz Ag Tetrahydropyridazines and pyridazinones as anti-inflammatory agents
US3586681A (en) * 1967-11-02 1971-06-22 Sandoz Ag 1,4,5,6-tetrahydropyridazines
US3752826A (en) * 1970-01-26 1973-08-14 Mcneilab Inc Aroyl substituted pyrroles
US4048191A (en) * 1975-06-27 1977-09-13 Mcneil Laboratories, Incorporated Halo-substituted 1-loweralkyl-5-aroylpyrrole-2-acetic acid compounds
JPS539788A (en) * 1976-07-14 1978-01-28 Syntex Inc 55aloyll1*22dihydroo3hh pyroro *1*22a* pyroll11 carboxylic acid derivative
US4089969A (en) * 1976-07-14 1978-05-16 Syntex (U.S.A.) Inc. 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
US4247551A (en) * 1979-09-17 1981-01-27 Gruppo Lepetit S.P.A. N-Pyrrolyl-pyridazineamines and their use as antihypertensive agents
US4347187A (en) * 1980-10-20 1982-08-31 Syntex (U.S.A.) Inc. Process for preparing 5-aroyl 1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acids and novel intermediates therein
IT1150070B (it) * 1980-12-22 1986-12-10 Lepetit Spa Procedimento per preparare derivati n-pirrolipiridazinamminici
AU8509882A (en) * 1981-06-30 1983-01-06 Merck & Co., Inc. Tricyclic derivatives of substituted pyrrole acids
JPS58501432A (ja) * 1981-09-11 1983-08-25 エスディ−エス・バイオテック・コ−ポレ−ション 抗炎症,鎮痛性4−ピリジルピリダジン(2h)−3−オン類
US4816454A (en) * 1984-09-21 1989-03-28 Cassella Aktiengesellschaft 4,5-dihydro-3(2H)-pyridazinones and their pharmacological use
GB8501372D0 (en) * 1985-01-18 1985-02-20 Smith Kline French Lab Chemical compounds
US5086052A (en) * 1987-07-17 1992-02-04 Abbott Laboratories Substituted 1,4,5,6-tetrahydro-2H-pyridazin-3-one and -3-thione compounds having lipoxygenase inhibitory activity
US4992441A (en) * 1987-10-14 1991-02-12 Mcneilab, Inc. 1-[[5-[[4-substituted-1-piperazinyl]methyl]-pyrrol-2-yl or furan-2-yl]methyl-2-piperidinones useful in treating schizophrenia
IE913866A1 (en) * 1990-11-28 1992-06-03 Ici Plc Aryl derivatives
ATE179756T1 (de) * 1992-09-22 1999-05-15 Univ Rochester Stabil transformierte säugertierzellen, die eine geregelte, entzündliche cyclooxygenase exprimieren
US5543297A (en) * 1992-12-22 1996-08-06 Merck Frosst Canada, Inc. Human cyclooxygenase-2 cDNA and assays for evaluating cyclooxygenase-2 activity
US5332736A (en) * 1993-11-01 1994-07-26 Ortho Pharmaceutical Corporation Anti-convulsant aroyl aminoacylpyrroles
US5622948A (en) * 1994-12-01 1997-04-22 Syntex (U.S.A.) Inc. Pyrrole pyridazine and pyridazinone anti-inflammatory agents
KR102081455B1 (ko) * 2017-06-09 2020-04-28 선상규 다중브러시를 이용한 직류발전장치

Also Published As

Publication number Publication date
AU3906295A (en) 1996-06-06
CN1132206A (zh) 1996-10-02
PL311536A1 (en) 1996-06-10
US5622948A (en) 1997-04-22
EP0714895A1 (en) 1996-06-05
NO954878D0 (no) 1995-11-30
CA2163490A1 (en) 1996-06-02
IL116139A0 (en) 1996-01-31
FI955783A (fi) 1996-06-02
KR960022506A (ko) 1996-07-18
MA23735A1 (fr) 1996-07-01
ZA9510027B (en) 1996-06-03
AR001771A1 (es) 1997-12-10
CN1066726C (zh) 2001-06-06
TR199501528A1 (tr) 1996-11-21
BR9505610A (pt) 1997-09-16
FI955783A0 (fi) 1995-12-01
JPH08208639A (ja) 1996-08-13
CZ316995A3 (en) 1996-06-12
HUT75117A (en) 1997-04-28
HU9503384D0 (en) 1996-01-29
NO954878L (no) 1996-06-03

Similar Documents

Publication Publication Date Title
CO4650183A1 (es) Derivados del pirrol
NO900941D0 (no) Arylpyrazolforbindelser, fremgangsmaate for deres fremstilling og anvendelse som pesticid innen landbruket.
FI904327A0 (fi) N-substituerad-4-pyrimidinaminer och -pyrimidindiaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
BR9307595A (pt) Composto, processo para sua preparação, composição herbicida, e, processo para danificar severamente ou exterminar plantas indesejáveis
AR246516A1 (es) Compuestos derivados de quinazolina, composiciones que los contienen y metodos para aplicarlos y para prepararlos.
YU34896A (sh) Supstituisani n-(indol-2-karbonil)-glicinamidi, njihovi intermedijeri i farmaceutske kompozicije
EE04310B1 (et) Bensimidasooli ühendid, neid ühendeid sisaldavad farmatseutilised kompositsioonid ja nende kasutamine
DK249089A (da) Benzamid-forbindelser, der er nyttige som protease-inhibitorer
MX9400190A (es) Derivados de tiazolidindiona, metodo para su obtencion y composicion farmaceutica que los contiene.
KR960041254A (ko) 상승적 안정화제 혼합물
DE69433984D1 (de) Arylpiperazinderivate von indol als liganden der rezeptoren 5 ht1-like, 5 ht1b und 5 ht1d
YU25593A (sh) Derivati acilaminoindola
MX9304387A (es) Derivado de 4-benzoilisoxazol, procedimiento para su preparacion y composicion herbicida que comprende tal derivado.
CO5080801A1 (es) Inhibidores de proteasas
ATE111460T1 (de) 2-(aminoalkyl)-5-(arylalkyl)1,3-dioxanderivate, ihre herstellung und ihre anwendung in der therapeutik.
NO910167D0 (no) Haarfargemiddel.
CO5170499A1 (es) 1,2,3,4,5, 6-hexahidro-2,6-metano-3-benzazocin-10-oles sustituidos con n-(5-fenil-tetrahidrofuranil)metilo y n-(6-fenil-tetrahidropiranil)metilo; procedimientos para prepararlos y su empleo como composiciones farmaceuticas
AR014847A1 (es) 4-amino-(etilamino)-oxindoles agonistas del autoreceptor de dopamina y una composicion farmaceutica que los comprende
PT87944A (pt) Processo para a preparacao de compostos 2-amino-5-hidroxi-4-pirimidonas
DE69835966D1 (de) Medizinische anwendungen von phenylalkanolen und derivaten davon
ATE132866T1 (de) 4-(4- oder 6-(trifluormethyl-2-pyridinyl)>-1- piperazinyl-alkyl substituierte laktame
NO900646L (no) Fremgangsmaate for fremstilling av calsiumantagonister.
AR012888A1 (es) 2-fenilpiridinas sustituidas y sus sales, procedimiento y compuestos intermediarios para su preparacion, las composiciones herbicidas, desecantesy/o defoliantes que contienen dichos compuestos y los procedimientos para combatir el crecimiento de plantas no deseadas y para desecar y/o defoliar
DK0591255T3 (da) Tetrahydrobenzazepinderivater der inhiberer lipoxygenase
DE69615200D1 (de) Asymetrische synthese von r und s warfarin und deren ähnlichen verbindungen